In addition to the shock of a cancer diagnosis and stress of treatment, cancer patients may also be at higher risk of severe illness from COVID-19 because their cancer, or its treatment, has left them more vulnerable to complications.
The National Cancer Institute (NCI) launched a long-term, nationwide study of COVID-19 in people with cancer called NCI COVID-19 in Cancer Patients Study (NCCAPS).
In this podcast episode, NCCS CEO Shelley Fuld Nasso speaks with leaders of the study] about how it will help scientists answer key questions about COVID-19’s impact on cancer patients, as well as cancer’s impact on the course of COVID-19. The findings have the potential to influence the treatment of cancer patients with COVID-19 in the future.
Cancer Convos: Survivorship. Advocacy. Policy
In Cancer Convos, leaders of the National Coalition for Cancer Survivorship talk with health care experts, providers, cancer survivors, caregivers, and advocates about cancer survivorship, advocacy, and policy efforts to improve cancer care. Shelley Fuld Nasso, NPP, is the CEO of this advocacy group with a strong mission. Formerly leading public policy with the Susan G. Komen Foundation, Shelley found her calling to advocacy as a dear friend lost his battle to cancer at only 43 years old. Now, she is bringing survivors and healthcare providers together with a new podcast. Lindsey Houff MPP is the Senior Policy Manager for NCCS. A dedicated advocate and graduate of Virginia Tech, Lindsey lost her father at a young age to Melanoma. The NCCS team is working to build a brighter future for those who have been affected by cancer. As NCCS aims to improve public policies, the advocates and survivors behind the story are inspiring and educational. Education, inspiration and connection, the keys to bringing survivors and healthcare together with a common goal; surviving cancer.